Nutritional senolytics and senomorphics: Implications to immune cells metabolism and aging - from theory to practice

Data de publicação:

Autores da FMUP

  • Paulo Miguel Da Silva Pereira

    Autor

  • Raquel Ângela Silva Soares Lino

    Autor

Participantes de fora da FMUP

  • Luis, C
  • Maduro, AT
  • Mendes, JJ
  • Ramalho, R

Unidades de investigação

Abstract

Aging is a natural physiological process, but one that poses major challenges in an increasingly aging society prone to greater health risks such as diabetes, cardiovascular disease, cancer, frailty, increased susceptibility to infection, and reduced response to vaccine regimens. The loss of capacity for cell regeneration and the surrounding tissue microenvironment itself is conditioned by genetic, metabolic, and even environmental factors, such as nutrition. The senescence of the immune system (immunosenescence) represents a challenge, especially when associated with the presence of age-related chronic inflammation (inflammaging) and affecting the metabolic programming of immune cells (immunometabolism). These aspects are linked to poorer health outcomes and therefore present an opportunity for host-directed interventions aimed at both eliminating senescent cells and curbing the underlying inflammation. Senotherapeutics are a class of drugs and natural products that delay, prevent, or reverse the senescence process - senolytics; or inhibit senescence-associated secretory phenotype - senomorphics. Natural senotherapeutics from food sources - nutritional senotherapeutics - may constitute an interesting way to achieve better age-associated outcomes through personalized nutrition. In this sense, the authors present herein a framework of nutritional senotherapeutics as an intervention targeting immunosenescence and immunometabolism, identifying research gaps in this area, and gathering information on concluded and ongoing clinical trials on this subject. Also, we present future directions and ideation for future clinical possibilities in this field.

Dados da publicação

ISSN/ISSNe:
2296-861X, 2296-861X

Frontiers in Nutrition  Frontiers Media S.A.

Tipo:
Article
Páginas:
-
PubMed:
36159455
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 26

Citações Recebidas na Scopus: 30

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • aging; immunometabolism; immunosenescence; inflammaging; nutritional senolytics; nutritional senomorphics; precision nutrition

Projetos associados

Effects of Xanthohumol on Metabolic Syndrome Progression (XAN4Health) - NCT03561116

Investigador Principal: Raquel Ângela Silva Soares Lino

Ensaio Clínico Académico (XAN4Health) . TA XAN . 2019

Correlation between clinical outcomes and spinopelvic parameters in patients with lumbar stenosis undergoing decompression surgery

Investigador Principal: Paulo Miguel da Silva Pereira

Estudo Clínico Académico (Lumbar stenosis) . 2020

Are Spinopelvic Parameters predictive of low back pain 8 years later in an asymptomatic population?

Investigador Principal: Paulo Miguel da Silva Pereira

Estudo Clínico Académico (Spinopelvic) . 2020

Long-term outcome of redo discectomy for recurrent lumbar disc herniations

Investigador Principal: Paulo Miguel da Silva Pereira

Estudo Clínico Académico (Lumbar disc) . 2021

SARS-CoV-2 e Angiogénese: uma ligação por explicar

Investigador Principal: Raquel Ângela Silva Soares Lino

Estudo Clínico Académico . 2021

Is the outcome after lumbar discectomy impacted by fatty infiltration of paraspinal muscles?

Investigador Principal: Paulo Miguel da Silva Pereira

Estudo Clínico Académico . 2021

Does sagittal alignment influence outcome for patients who undergo anterior cervical fusion for degenerative pathologies?

Investigador Principal: Paulo Miguel da Silva Pereira

Estudo Clínico Académico . 2020

Partilhar a publicação